Claire Fraser - 10 Apr 2025 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Issuer symbol
MCRB
Transactions as of
10 Apr 2025
Net transactions value
$0
Form type
4
Filing time
11 Apr 2025, 16:05:15 UTC
Previous filing
30 Jan 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 10 Apr 2025 Common Stock 100,000 $0.5800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders.